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1. Introduction
   Urinary tract infection (UTI) is defined as the presence 
of significant numbers of pathogenic bacteria, or other 
organisms, in the urinary system[1]. UTIs are among the most 
common bacterial diseases worldwide that can be presented 
asymptomatic or symptomatic, characterized by a wide 
spectrum of symptoms ranging from mild irritative voiding 
to bacteremia, sepsis, or even death. Fifty percent of all 
women will experience at least once UTI in their lifetime 
and about 25% of them will have one or more recurrent 
infections[2]. In latter decades, widespread utilization 
PEER REVIEW                            ABSTRACT
KEYWORDS
Drug resistance, Urinary tract infections, Anti-bacterial agents, Sensitivity, Shalamzar
Objective: To investigate drug resistance of various strains of Escherichia coli (E. coli) bacteria 
isolated from female patients with urinary tracts infections (UTIs) in Shalamzar, Iran.
Methods: This study was conducted from April 2011 to April 2012 on 150 female patients with 
positive urine culture and 105 CFU/mL colony count. The pattern of antibiotic sensitivity was 
recognized using antibiogram by the disc diffusion method.
Results: The results revealed that the predominant bacterium was E. coli (90%), followed by 
Klebsiella pneumonia (3%). Trimethoprim-sulfamethoxazole is the initial medicine to treat UTIs 
(without complications) which demonstrated relatively poor activity against E. coli (with 40% 
sensitivity), though alternative medicines such as nitrofurantoin (97% sensitivity) and ciprofloxacin 
(91% sensitivity) showed good activity against E. coli as well.
Conclusions: The findings emphasized the necessity of pursuing the investigations in national 
and local governments in order to retain the efficacy of treating UTIs using effective antibiotics.
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Comments
This study is useful in which the 
authors investigate drug resistance 
of various strains of E. coli bacteria 
isolated from female patients with 
UTIs in South West of Iran. The current 
research was conducted for the first 
time in this region (Shalamzar). From 
this study, it revealed that there were 
many factors leading to drug resistance 
such as prescription of antibiotics 
wi thout  evaluat ing sensi t iv i ty , 
indiscr iminate  prescr ip t ion  o f 
antibiotics by doctors without ultimate 
diagnosis of the infectious agent and 
intractable antibiotic use by people. 
So it is important to use sensitivity 
pattern for health care systems.
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of antibiotics has resulted in the increase incidence of 
antibiotic resistance among urinary tract pathogens all over 
the world[3,4].
   UTIs is one of the people’s health problems in all age 
groups all over the world[5]. UTIs annually infect about 
millions of individuals and impose million dollars on 
health care systems[4,6]. Approximately one third women 
will require antimicrobial treatment for UTI before 24 years 
of age, and 40% to 50% of women will have UTI during their 
lifetime. UTIs in male patients are considered complicated. 
Escherichia coli (E. coli) is the most common cause of 
UTIs[7,8]. Furthermore, about 20% to 40% of women experience 
an infection relapse seemingly due to the emergence of 
UTIs antibacterial resistance. Increasing rates of resistance 
among bacterial uropathogens has caused growing 
concerns in both developed and developing countries[9]. 
The pathogenecity depends on the expression of an array of 
virulence factors produced by E. coli. Toxigenic strains of 
E. coli are primarily of three types: enterotoxigenic E. coli 
(ETEC), Shiga toxigenic E. coli (STEC) and necrotoxigenic E. 
coli (NTEC)[10]. Apparently, the medical community around 
the world has failed to solve the threatening problem of 
antibiotic resistance growth for which a significant reason 
is the inappropriate use of antibiotics. Suitable data on the 
patterns of drug sensitivity may help health authorities to 
select appropriate antibiotics for patients while providing 
the researchers with control over the epidemic patterns of 
antibiotic resistance across the city. The determination of 
sensitivity patterns is significant in that antibiotic-resistant 
patterns differ geographically[11-13]. The bacterial resistance 
may be the effect of antibiotic overuse and self-medication.
The purpose of this study was to examine the drug resistance 
of various strains of E. coli bacteria isolated from female 
patients with UTIs in Shalamzar. Data analysis can examine 
the sensitivity of such bacteria to antibiotics, consequently 
investigating their sensitivity in different populations which 
may lead to reasonable selection of antibiotics for UTIs in the 
city[14].
2. Materials and methods
   All women with positive results for E.coli culture in 
primary tests were referred to Central Laboratory of 
Shalamzar. In the laboratory, each sample was cultured 
in three different mediums including blood agar, Eosin 
Methylene blue and MacCongey’s agar and incubated for 
24 h at 37 °C. One hundred and fifty strains of bacteria 
were isolated from 500 cultured samples (90% E. coli; 135 
strains). All suspected colonies were detected through 
colony morphology, Gram staining, catalase positivity, 
oxidase negativity and other biochemical reactions. Patients’ 
information and features and their treatment procedures 
were recorded in the lab’s computer. The study was 
conducted in a one-year period, from April 2011 to April 
2012. The pattern of antibiotic sensitivity was recognized 
using antibiogram by the disc diffusion method. Bacteria 
were divided in three classes as high sensitive, moderate 
sensitive and resistant. The classification was performed 
according to National Committee for Clinical Laboratory 
Standards[15]. The control sample to determine the bacterium 
sensitivity was E. coli ATTC 25922.
3. Results
   The predominant isolated bacterial species were E. 
coli which approximately constituted 90% percent of total 
isolations followed by 3% Klebsiella pneumoni. The rest 
frequency of isolated bacteria were Enterococcus spp.(2%), 
coagulase-negative Staphylococci (2%), Staphylococcus 
saprofiticus (1.8%), Proteus mirabilis (1%), Citrobacter 
spp. (0.6%) and Enterobacter spp. (0.6%). Trimethoprim-
sulfamethoxazole (TMP-SMZ) which was the first line of 
treatment for urinary infections had little effect on isolated 
E. coli (40% sensitivity). In addition alternative medicines 
such as ciprofloxacin and nitrofurantoin demonstrated good 
effects against E. coli (91%-97% sensitivity). All samples 
were highly sensitive to nitrofurantoin and ciprofloxacin, 
moderately sensitive to TMP-SMZ, gentamicin, cefazolin and 
tetracycline and were resistant to ampicillin and penicillin. 
Fluoroquinolones was successfully applied from 2011 to 2012 
for curing patients; all 150 patients with positive culture and 
10
5 CFU/mL colony count were cured by fluoroquinolones. 
Individuals’ age range were 18-40 and age distribution 
was as follows: 45.3% of patients were 18-22 years old, 4.7% 
were 22-25 years old and 50% were between 25-40 years 
old. Nearly all colonies were resistant to ampicillin and 
penicillin and only 40% of the E. coli colonies were sensitive 
to TMP-SMZ and the highest sensitivity of isolated E.coli 
colonies (97%) was against nitrofurantoin.
4. Discussion
   The current research was conducted for the first time 
in this region (Shalamzar) and apparently there had been 
problems which caused the drug resistance including the 
lack of clinical diagnostic laboratories in the past years, 
which led to prescription of antibiotics without evaluating 
sensitivity, indiscriminate prescription of antibiotics by 
doctors without ultimate diagnosis of the infectious agent 
and intractable antibiotic use by people. The majority of 
clients were from near villages. The reason why they took 
antibiotics intractably was the lack of knowledge of the 
side effects and risks of drug resistance; and the lack of full 
insurance coverage caused them not to visit the doctor. All 
isolated bacteria were resistant to ampicillin and penicillin, 
though 60% of them showed resistance to TMP-SMZ, which 
may be a serious alarm for indiscriminate use of this 
medicine. A study in Minnesota, USA revealed that E. coli 
resistance to TMP-SMZ was higher in samples than controls, 
i.e. resistance to this medicine[16]. Another study in Norway 
endorsed E. coli resistance to fluoroquinolones and TMP-SMZ 
and also resistant genes were explored[17]. The resistance in 
this area was associated with risk factors such as medicine 
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overselling and excessive self-medication. In this area, 
ampicillin, ciprofloxacin and TMP-SMZ are easily provided 
and used. Moreover according to topics published by the 
society of infectious diseases, TMP-SMZ is the first without-
complications-medicine in UTIs treatment[18]. Therefore 
self-medication with such medicine provides resistance. 
Recent published studies confirm that resistance to TMP-
SMZ in parts of the world is increasing; furthermore the 
present study also endorses the situation, such that 60% of 
patients were resistant to this medicine[19-22]. Our results 
imply that taking TMP-SMZ is not so specific to this area and 
alternative medicines (fluoroquinolones and nitrofurantoin) 
recommended by Infectious Diseases Society of America 
to cure UTIs can be used. Fluoroquinolones were examined 
in the present study (ciprofloxacin) to which E. coli 
demonstrated high sensitivity. In addition, nitrofurantoin 
revealed such sensitivity as well such that 97% of E.coli 
strains were highly sensitive. In a study, Sangeeth et al. 
concluded that the increased resistance to fluoroquinolones 
in E. coli could be due to its inappropriate usage[23]. It is 
imperative to rationalize the use of fluoroquinolones in 
order to prevent the dissemination of resistant strains in 
the population[23].
   UTIs are normally due to bacterial infections which may 
occur during a person’s life. Unfortunately most of the 
treatments begin to be prior to the results of the culture; as 
a consequence the results of the sensitivities differ with the 
previous studies. Therefore the study of resistance among 
uropathogens is important to prescribe appropriate medicine 
and to prevent indiscriminate prescription in order to 
decline the medical resistance. Such studies can be useful 
for determining the risk factors of bacterial resistance[24]. 
Increasing occurrence of multiple β-lactamases in 
clinical isolates could lead to therapeutic failure. Hence, 
early detection of β-lactamase production can benefit 
implementation of proper antibiotic therapy and infection 
control policies[25]. 
   In similar work, Jalilian et al. confirms that E. coli is still 
the most common isolated uropathogen[26]. Augmentin and 
amikacin are not as a first choice for treatment of UTI in 
Kermanshah Area. Ampicillin and nitrofurantoin may be 
considered as the first choice empiric agent to out-patients.
   In a study, Thiraviam et al. concluded that a high 
number of E. coli strains isolated from both diabetic and 
non diabetic patients showed resistant to the antibiotic 
rifampicin and ciprofloxacin[27]. However, the resistant 
to rifampicin was more than the ciprofloxacin. The 
representative isolates lost their antibiotic resistance after 
curing hence it was inferred that the antibiotic resistant was 
plasmid borne.
   Further investigation in national levels and preventive 
measures for medical resistance are required. Further 
research should be directed on determining the resistant 
strains of bacteria, their polymorphism, and epidemiology 
and how they spread; inattention to resistance mechanisms, 
spread and degree of prevalence may hinder treatment of 
bacterial infections and medicines intractable use[28].
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Comments 
Background
   Investigating bacterial sensitivity patterns of uropathogens 
in national and local levels provides significant data 
regarding the emergence of antibiotic resistance issues in 
order to help health management system. The aim of this 
study was to investigate drug resistance of various strains 
of E. coli bacteria isolated from female patients with UTIs in 
South West of Iran.
  
Research frontiers
   UTIs arouse people’s health problems in all age groups 
all over the world. UTIs annually infect about millions of 
individuals and impose million dollars on health care 
systems. Thus defining bacterial sensitivity pattern of 
women with UTIs is very important for health care systems.
Related reports
   Jalilian et al. confirms that E. coli is still the most 
common isolated uropathogen. Augmentin and amikacin 
are not as a first choice for treatment of UTI in Kermanshah 
area. Thiraviam et al. concluded that a high number of E. 
coli strains isolated from both diabetic and non diabetic 
patients showed resistant to the antibiotic rifampicin and 
ciprofloxacin.
Innovations & breakthroughs
   The acquired results implicate sensitivity of isolated 
bacteria to antibiotics, investigating their sensitivity in 
different populations which may lead to good selection of 
antibiotics for UTIs in region of study.
Applications
   Epidemiological results of bacterial sensitivity pattern of 
women with UTIs are very significant for drug medication 
and prevention.
Peer review
   This study is useful in which the authors investigate drug 
resistance of various strains of E. coli bacteria isolated 
from female patients with UTIs in South West of Iran. The 
current research was conducted for the first time in this 
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region (Shalamzar). From this study, it revealed that there 
were many factors leading to drug resistance such as 
prescription of antibiotics without evaluating sensitivity, 
indiscriminate prescription of antibiotics by doctors 
without ultimate diagnosis of the infectious agent and 
intractable antibiotic use by people. So it is important to 
use sensitivity pattern for health care systems.
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